Diagnostic and Prognostic Value of Circulating miR-221 for Extranodal Natural Killer/T-Cell Lymphoma

per Guo, Hong-Qiang, Huang, Guo-Liang, Guo, Cheng-Cheng, Pu, Xing-Xiang, Lin, Tong-Yu
Publicat 2010

EGFR inhibitors sensitize non–small cell lung cancer cells to TRAIL-induced apoptosis

per Xu, Fei, Tian, Ying, Huang, Yan, Zhang, Ling-Ling, Guo, Zheng-Zheng, Huang, Jia-Jia, Lin, Tong-Yu
Publicat 2011

Efficacy of gemcitabine combined with oxaliplatin, L-asparaginase and dexamethasone in patients with newly-diagnosed extranodal NK/T-cell lymphoma

per GUO, HONG-QIANG, LIU, LEI, WANG, XIN-FENG, LIN, TONG-YU, YAO, SHU-NA, YAO, ZHI-HUA, YANG, SHU-JUN
Publicat 2014

Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphom...

per Wang, Jing-hua, Wang, Liang, Liu, Cheng-cheng, Xia, Zhong-jun, Huang, Hui-qiang, Lin, Tong-yu, Jiang, Wen-qi, Lu, Yue
Publicat a Oncotarget (2016)

A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution

per Huang, Jia-Jia, Xia, Yi, Wang, Yu, Liu, Pan-Pan, Bi, Xi-Wen, Sun, Peng, Lin, Tong-Yu, Jiang, Wen-Qi, Li, Zhi-Ming
Publicat a Oncotarget (2016)

Cyclosporine, prednisone, and high-dose immunoglobulin treatment of angioimmunoblastic T-cell lymphoma refractory to prior CHOP or CHOP-like regimen

per Chen, Xing-Gui, Huang, He, Tian, Ying, Guo, Cheng-Cheng, Liang, Chao-Yong, Gong, Yao-Ling, Zou, Ben-Yan, Cai, Rui-Qing, Lin, Tong-Yu
Publicat 2011

Expression of BAFF and BAFF-R in Follicular Lymphoma: Correlation with Clinicopathologic Characteristics and Survival Outcomes

per Li, Ya-Jun, Jiang, Wen-Qi, Rao, Hui-Lan, Huang, Jia-Jia, Xia, Yi, Huang, Hui-Qiang, Lin, Tong-Yu, Xia, Zhong-Jun, Li, Su, Li, Zhi-Ming
Publicat 2012

Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma

per Huang, Jia-Jia, Li, Ya-Jun, Xia, Yi, Wang, Yu, Wei, Wen-Xiao, Zhu, Ying-Jie, Lin, Tong-Yu, Huang, Hui-Qiang, Jiang, Wen-Qi, Li, Zhi-Ming
Publicat 2013

Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis

per Song, Chen-Ge, Huang, Jia-Jia, Li, Ya-Jun, Xia, Yi, Wang, Yu, Bi, Xi-Wen, Jiang, Wen-Qi, Huang, Hui-Qiang, Lin, Tong-Yu, Li, Zhi-Ming
Publicat a PLoS One (2015)

Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors

per Huang, JiaJia, Jiang, WenQi, Xu, RuiHua, Huang, HuiQiang, Lv, Yue, Xia, ZhongJun, Sun, XiaoFei, Guan, ZhongZhen, Lin, TongYu, Li, ZhiMing
Publicat 2010

High risk of deep vein thrombosis associated with peripherally inserted central catheters in lymphoma

per Zhang, Xi, Huang, Jia-Jia, Xia, Yi, Li, Chao-Feng, Wang, Yu, Liu, Pan-Pan, Bi, Xi-Wen, Sun, Peng, Lin, Tong-Yu, Jiang, Wen-Qi, Li, Zhi-Ming
Publicat a Oncotarget (2016)

Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study

per Hu, Li-Yang, Xu, Xiao-Lu, Rao, Hui-Lan, Chen, Jie, Lai, Ren-Chun, Huang, Hui-Qiang, Jiang, Wen-Qi, Lin, Tong-Yu, Xia, Zhong-Jun, Cai, Qing-Qing
Publicat a Chin J Cancer (2017)

Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group

per Yoon, Dok Hyun, Cao, Junning, Chen, Tsai-Yun, Izutsu, Koji, Kim, Seok Jin, Kwong, Yok Lam, Lin, Tong Yu, Thye, Lim Soon, Xu, Bing, Yang, Deok Hwan, Kim, Won Seog
Publicat a J Hematol Oncol (2020)

New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study

per Cai, Qing-Qing, Hu, Li-Yang, Geng, Qi-Rong, Chen, Jie, Lu, Zhen-Hai, Rao, Hui-Lan, Liu, Qing, Jiang, Wen-Qi, Huang, Hui-Qiang, Lin, Tong-Yu, Xia, Zhong-Jun
Publicat a Chin J Cancer (2016)

Serum C-Reactive Protein (CRP) as a Simple and Independent Prognostic Factor in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

per Li, Ya-Jun, Li, Zhi-Ming, Xia, Yi, Huang, Jia-Jia, Huang, Hui-Qiang, Xia, Zhong-Jun, Lin, Tong-Yu, Li, Su, Cai, Xiu-Yu, Wu-Xiao, Zhi-Jun, Jiang, Wen-Qi
Publicat 2013

BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma

per Tian, Xiao‐Peng, Cai, Jun, Ma, Shu‐Yun, Fang, Yu, Huang, Hui‐Qiang, Lin, Tong‐Yu, Rao, Hui‐Lan, Li, Mei, Xia, Zhong‐Jun, Kang, Tie‐Bang, Xie, Dan, Cai, Qing‐Qing
Publicat a Cancer Commun (Lond) (2020)

Blood Lymphocyte-to-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated with R-CHOP

per Li, Zhi-Ming, Huang, Jia-Jia, Xia, Yi, Sun, Jian, Huang, Ying, Wang, Yu, Zhu, Ying-Jie, Li, Ya-Jun, Zhao, Wei, Wei, Wen-Xiao, Lin, Tong-Yu, Huang, Hui-Qiang, Jiang, Wen-Qi
Publicat 2012

Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survi...

per Chen, Kai-Lin, Chen, Jie, Rao, Hui-Lan, Guo, Ying, Huang, Hui-Qiang, Zhang, Liang, Shao, Jian-Yong, Lin, Tong-Yu, Jiang, Wen-Qi, Zou, De-Hui, Hu, Li-Yang, Wirian, Michael Lucas, Cai, Qing-Qing
Publicat a Chin J Cancer (2015)

Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer

per Xu, Da-zhi, Geng, Qi-rong, Tian, Ying, Cai, Mu-yan, Fang, Xin-juan, Zhan, You-qing, Zhou, Zhi-wei, Li, Wei, Chen, Ying-bo, Sun, Xiao-wei, Guan, Yuan-xiang, Li , Yuan-fang, Lin, Tong-yu
Publicat 2010

Low initial trough concentration of rituximab is associated with unsatisfactory response of first-line R-CHOP treatment in patients with follicular lymphoma with grade 1/2

per Liu, Shu, Huang, He, Chen, Rong-xin, Wang, Zhao, Guan, Yan-ping, Peng, Chen, Fang, Xiao-jie, Chen, Zhuo-jia, Guan, Shao-xing, Zhu, Xia, Ren, Quan-guang, Yao, Yu-yi, Huang, Hong-bing, Huang, Min, Wang, Xue-ding, Lin, Tong-yu
Publicat a Acta Pharmacol Sin (2020)